International Association for the Study of Lung Cancer

About International Association for the Study of Lung Cancer

The International Association for the Study of Lung Cancer’s largest recent grant went to the Lung Cancer Research Foundation, a $425,000 award in 2025. That single grant is a useful window into how the foundation gives: it backs lung cancer research organizations, major cancer centers, and institutions working on clinical and translational questions tied to lung cancer and related thoracic malignancies. Another 2025 grant, $87,500 to the Lung Cancer Foundation of America, shows support for a lung cancer-specific nonprofit focused on the disease community. The remaining recent awards are smaller, $50,000 grants to major research institutions including Dana-Farber Cancer Institute, Fred Hutchinson Cancer Research Center, University of California, Los Angeles, and Mayo Clinic. Across those awards, the foundation appears to favor established partners with research infrastructure and disease-specific expertise. Its active programs also point to a global research orientation, including an IASLC Research Grant Program and a joint partnership with the Lung Cancer Research Foundation centered on oncogene-driven lung cancer. The overall picture is a funder built around lung cancer science, collaborative research, and patient-focused advancement rather than broad community grantmaking.

What International Association for the Study of Lung Cancer Funds

A clear throughline in the foundation’s grantmaking is support for lung cancer research organizations. In 2025, it gave $425,000 to the Lung Cancer Research Foundation and $87,500 to the Lung Cancer Foundation of America, both of which sit squarely in the disease-specific research and advocacy space. The foundation also funds major research and clinical institutions. It awarded $50,000 to Dana-Farber Cancer Institute for lung cancer work and another $50,000 to Fred Hutchinson Cancer Research Center, signaling interest in established centers with active cancer science programs. The same pattern appears in university-based research support: the University of California, Los Angeles received $50,000. Its active grant programs reinforce that focus, with research funding opportunities aimed at biomarker testing, molecular testing, staging projects, and thoracic oncology. The stated scope also includes related thoracic malignancies, not just lung cancer alone.

How International Association for the Study of Lung Cancer Gives